Crypto exchange choices are difficult; platforms claim the best fees, tokens, and safety. MEXC, active since 2018, grows ...

Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion. The offer – which is a 62% premium over Array’s closing share price on Friday – would ...

Dive into The Register's online archive of incisive tech news reporting, features, and analysis dating back to 1998 ...